Analyst Ratings for Spark Therapeutics (ONCE)

ONCE Rating Summary

  |   Expand Research on ONCE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.2 / 10   Percentile Rank: 16%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/25/2019 Barclays Gena Wang Downgrade Equalweight
(Overweight)		 115.00
(74.00)		 113.27
(110.05)		 -2.84% Details
3/7/2019 William Blair Raju Prasad Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 113.70
(110.05)		 -3.21% Details